Prenatal exposure to cigarette smoke causes persistent changes in the oxidative balance and in DNA structural integrity in rats submitted to the animal model of schizophrenia

Journal of Psychiatric Research

Volumn 45, Issue 11, 2011, Pages 1497-1503

  Fraga, Daiane B ^a   Deroza, Pedro F ^a   Ghedim, Fernando V ^a   Steckert, Amanda V ^a   De Luca, Renata D ^a   Silverio, Alexandre ^a   Cipriano, Andreza L ^a   Leffa, Daniela D ^a   Borges, Gabriela D ^a   Quevedo, João ^a   Pinho, Ricardo A ^a   Andrade, Vanessa M ^a   Dal Pizzol, Felipe ^a   Zugno, Alexandra I ^a  

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

Author keywords

DNA damage; Oxidative stress; Pregnant smoking; Schizophrenia

Indexed keywords

BRAIN PROTEIN; CARBONYL DERIVATIVE; CIGARETTE SMOKE; KETAMINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMET ASSAY; CONTROLLED STUDY; CORPUS STRIATUM; DNA DAMAGE; DNA STRUCTURE; EXPERIMENTAL RAT; FEMALE; HIPPOCAMPUS; LIPID BRAIN LEVEL; LIPID PEROXIDATION; MALE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PASSIVE SMOKING; PREFRONTAL CORTEX; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN METABOLISM; RAT; SCHIZOPHRENIA;

EID: 80053934171     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.06.007     Document Type: Article

References (94)

1. Allen R.G., Tresini M. Oxidative stress and gene regulation. Free Radical and Biology Medicine 2000, 28:463-499.
2. Baykan A., Narin N., Narin F., Akgün H., Yavaşcan S., Saraymen R. The protective effect of melatonin on nicotine-induced myocardial injury in newborn rats whose mothers received nicotine. Anadolu Kardiyoloji Dergisi 2008, 8:243-248.
3. Baguelin-Pinaud A., Robert S., Menard J.-F., Thibaut F. Prenatal exposure to tobacco and risk for schizophrenia: a retrospective epidemiological study. Comprehensive Psychiatric 2010, 51:106-109.
4. Becker A., Grecksch G. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2004, 28:1267-1277.
5. Becker A., Peters B., Schroeder H., Mann T., Huether G., Grecksch G. Ketamine-induced changes in rat behavior: a possible animal model of schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2003, 27:687-700.
6. Bermudez E.A., Rifai N., Buring J.E., Manson J.E., Ridker P.M. Relation between markers of systemic vascular inflammation and smoking in women. American Journal of Cardiology 2002, 89:1117e9.
7. Bhagwat S.V., Vijayasarathy C., Raza H., Mullick J., Avadhani N.G. Preferential effects of nicotine and 4-(N-methyl-N-nitrosamine)-1-(3-pyridyl)-1-butanone on mitochondrial glutathione S-transferase A4-4 induction and increased oxidative stress in the rat brain. Biochemical Pharmacology 1998, 56:831-839.
8. Bowie C.R., Harvey P.D. Schizophrenia from a neuropsychiatric perspective. Mont Sinai Journal Medicine 2006, 73:993-998.
9. Boksa P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain, Behavior and Immunity 2010, 24:881-897.
10. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Archives of General Psychiatry 2004, 61:774-780.
11. Brown A.S. Prenatal infection as a risk factor for schizophrenia. Schizophrenia Bulletin 2006, 32:200-202.
12. Brown A.S., Susser E.S. In utero infection and adult schizophrenia. Mental Retardation and Developmental Disabilities Research Reviews 2002, 8:51-57.
13. Brown A.S. The environment and susceptibility to schizophrenia. Progress in Neurobiology 2011, 93:23-58.
14. Cannon M., Jones P.B., Murray R.M. Obstetric complications and schizophrenia: historical and meta-analytic review. American Journal of Psychiatry 2002, 159:1080-1092.
15. Chang M.L., Yang J., Kem S., Klaidman L., Sugawara T., Chan P.H., et al. Nicotinamide and ketamine reduce infarct volume and DNA fragmentation in rats after brain ischemia and reperfusion. Neuroscience Letters 2002, 322:137-140.
16. Collins A.R. The comet assay for DNA damage and repair: principles, applications, and limitations. Molecular Biotechnology 2004, 26:249-261.
17. Coppedè F., Migliore L. Evidence linking genetics, environment, and epigenetics to impaired DNA repair in Alzheimer's disease. Journal of Alzheimers Disease 2010, 20:953-966.
18. Csernansky J.G., Martin M., Shah R., Bertchume A., Colvin J., Dong H. Cholinesterase inhibitors ameliorate behavioral deficts induced by MK-801 in mice. Neuropsychopharmacology 2005, 30:2135-2143.
19. Dal-Pizzol F., Ritter C., Cassol- O.J., Rezin G.T., Petronilho F., Zugno A.I., et al. Oxidative mechanisms of brain dysfunction during sepsis. Neurochemical Research 2010, 35:1-12.
20. De Assis K.R., Ladeira M.S., Bueno R.C., dos Santos B.F., Dalben I., Salvadori D.M. Genotoxicity of cigarette smoking in maternal and newborn lyphocytes. Mutation Research 2009, 679:72-78.
21. De Oliveira L., Fraga D.B., De Luca R.D., Canever L., Ghedim F.V., Matos M.P., et al. Behavioral changes and mitochondrial dysfunction in a rat modelo f schizophrenia induced by ketamine. Matabolic Brain Disease 2011, 26:69-77.
22. De Oliveira L., Spiazzi C.M., Bortolin T., Canever L., Petronilho F., Mina F.G., et al. Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats. Progress in Neuropsychofarmacology and Biology Psychiatry 2009, 33:1003-1008.
23. Di Chiara G. Role of dopamine in the behavioural actions of nicotine related to addiction. European Journal Pharmacology 2000, 393:295-314.
24. Do K.Q., Cabungcal J.H., Frank A., Steullet P., Cuenod M. Redox dysregulation, neurodevelopment, and schizophrenia. Current Opinion Neurobiology 2009, 19:220-230.
25. Duncan G.E., Leipzig J.N., Mailman R.B., Lieberman J.A. Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation. Brain Research 1998, 812:65-75.
26. Draper H.H., Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods in Enzymology 1990, 186:421-431.
27. Featherstone R.E., Kapur S., Fletcher P.J. The amphetamine-induced sensitized state as a model of schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2007, 31:1556-1571.
28. Gatzke-Koop L.M. The canary in the coalmine: the sensitivity of mesolimbic dopamine to environmental adversity during development. Neuroscience and Biobehavioral Reviews 2010, 35:794-803.
29. Grima G., Benz B., Parpura V., Cuénod M., Do K.Q. Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia. Schizophrenia Research 2003, 62:213-224.
30. Gunes T., Koklu E., Gunes I., Narin F., Koklu S. Influence of maternal nicotine exposure on neonatal rat oxidant-antioxidant system and effect of ascorbic acid supplementation. Human Experimental Toxicology 2008, 27:781-786.
31. Gutowicz M. The influence of reactive oxygen species on the central nervous system. Postepy Higiene and Experimental Medicine 2011, 65:104-113.
32. Halliwell B. Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radical Research 1999, 31:261-272.
33. Haukvik U.K., Lawyer G., Bjerkan P.S., Hartberg C.B., Jönsson E.G., Mcneil T., et al. Cerebral cortical thickness and a history of obstetric complications in schizophrenia. Journal of Psychiatric Research 2009, 43:1287-1293.
34. Hroudová J., Fišar Z. Connectivity between mitochondrial functions and psychiatric disorders. Psychiatric and Clinical Neurosciences 2011, 65:130-141.
35. Huang H.S., Akbarian S. GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia. PLoS One 2007, 2:e809.
36. Hunt M.J., Raynaud B., Garcia R. Ketamine dose-dependently unduces high-frequency oscillations in the nucleus accumbens in freely moving rats. Biology Psychiatry 2006, 60:1206-1214.
37. Ishihama T., Ago Y., Shintani N., Hashimoto H., Baba A., Takuma K., et al. Environmental factors during early developmental period influence psychobehavioral abnormalities in adult PACAP-deficient mice. Behavioral Brain Research 2010, 209:274-280.
38. Izzotti A., Balansky R.M., Cartiglia C., Camoirano A., Longobardi M., De Flora S. Genomic and transcriptional alterations in mouse fetus liver after transplacental exposure to cigarette smoke. FASEB Journal 2003, 17:1127-1129.
39. Jentsch J.D., Taylor J.R., Roth R.H. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion. Neuropsychopharmacology 1998, 19:105-113.
40. Junn E., Mouradian M.M. Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. Journal of Neurochemistry 2001, 78:374-383.
41. Kleijn J., Folgering J.H., Van der Hart M.C., Rollema H., Cremers T.I., Westerink B.H. Direct effect of nicotine on mesolimbic dopamine release in rat nucleus accumbens shell. Neuroscience Letters 2011, 493:55-58.
42. Kosecik M., Erel O., Sevinc E., Selek S. Increased oxidative stress in children exposed to passive smoking. International Journal of Cardiology 2005, 100:61-64.
43. Kopsida E., Mikaelsson M.A., Davies W. The role of imprinted genes in mediating susceptibility to neuropsychiatric disorders. Hormone and Behavior 2011, 59:375-382.
44. Laruelle M., Innis R.B. Images in neuroscience. SPECT imaging of synaptic dopamine. American Journal Psychiatry 1996, 153:1249-1254.
45. Leroy C., Bragulat V., Berlin I., Grégoire M.C., Bottlaender M., Roumenov D., et al. Cerebral monoamine oxidase A inhibition in tobacco smokers confirmed with PET and [11C] befloxatone. Journal of Clinical Psychopharmacology 2009, 29:86-88.
46. Levine R.L., Williams J.A., Stadtman E.R., Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods in Enzymology 1994, 233:346-357.
47. Li S., Kim K.Y., Kim J.H., Park M.S., Bahk J.Y., Kim M.O. Chronic nicotine and smoking treatment increases dopamine transporter mRNA expression in the rat midbrain. Neuroscience Letters 2004, 363:29-32.
48. Ling Z., Gayle D.A., Ma S.Y., Lipton J.W., Tong C.W., Hong J.S., et al. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Movement Disorders 2002, 17:116-124.
49. Lodge D.J., Grace A.A. Amphetamine activation of hippocampal drive of mesolimbic dopamine neurons: a mechanism of behavioral sensitization. Journal of Neuroscience 2008, 28:7876-7882.
50. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biologycal Chemistry 1951, 193:265-275.
51. Maciag A., Bialkowska A., Espiritu I., Powell D., Alvord W.G., Kasprzak K.S., et al. Gestation stage-specific oxidative deoxyribonucleic acid damage from sidestream smoke in pregnant rats and their fetuses. Archives of Environment Health 2003, 58:238-244.
52. McArthur S., McHale E., Dalley J.W., Buckingham J.C., Gillies G.E. Altered mesencephalic dopaminergic populations in adulthood as a consequence of brief perinatal glucocorticoid exposure. Journal of Neuroendocrinology 2005, 17:475-482.
53. Martínez-Téllez R.I., Hernández-Torres E., Gamboa C., Flores G. Prenatal stress alters spine density and dendritic length of nucleus accumbens and hippocampus neurons in rat offspring. Synapse 2009, 63:794-804.
54. Meyer U., Feldon J. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Progress in Neurobiology 2010, 90:285-326.
55. Miller L.R., Mukherjee S., Ansah T.A., Das S.K. Cigarette smoke and dopaminergic system. Journal of Biochemical and Molecular Toxicology 2007, 21:325-335.
56. Molz S., Tharine D.C., Decker H., Tasca C.I. GMP prevents excitotoxicity mediated by NMDA receptor activation but not by reversal activity of glutamate transporters in rat hippocampal slices. Brain Research 2008, 1231:113-120.
57. Mooney L.A., Santella R.M., Covey L., Jeffrey A.M., Bigbee W., Randall M.C., et al. Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation. Cancer Epidemiology Biomarkers and Prevention 1995, 4:627-634.
58. Mössner R., Dringen R., Persico A.M., Janetzky B., Okladnova O., Albert D., et al. Increased hippocampal DNA oxidation in serotonin transporter deficient mice. Journal of Neural Transmission 2002, 109:557-565.
59. Müller N., Schwarz M.J. Immune system and schizophrenia. Current Immunology Reviews 2010, 6:213-220.
60. Nisell M., Nomikos G.G., Svensson T.H. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 1994, 16:36-44.
61. Pazvantoglu O., Selek S., Okay I.T., Sengul C., Karabekiroglu K., Dilbaz N., et al. Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile. Psychiatry Clinical Neuroscience 2009, 63:693-700.
62. Picada J.N., Roesler R., Henriques J.A. Genotoxic, neurotoxic and neuroprotective activities of apomorphine and its oxidized derivative 8-oxo-apomorphine. Brazilian Journal of Medicine and Biology Research 2005, 38:477-486.
63. Prabakaran S., Swatton J.E., Ryan M.M., Huffaker S.J., Huang J.T.-J., Griffin J.L., et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Molecular of Psychiatry 2004, 9:684-697.
64. Patterson P.H. Maternal influenza infection leads to neuropathology and behavioral abnormalities in adult offspring. Neuropsychopharmacology 2005, 30:S9.
65. Ptak C., Petronis A. Epigenetic approaches to psychiatric disorders. Dialogues Clinical Neuroscience 2010, 12:25-35.
66. Radonji'c N.V., Petronijevi N.D., Vuckovi S.M., Prostran M.S., Nesi Z.I., Todorovi V.R., et al. Baseline temperature in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration. Physiology and Behavior 2008, 93:437-443.
67. Reid M.S., Fox L., Ho L.B., Berger S.P. Nicotine stimulation of extracellular glutamate levels in the nucleus accumbens: neuropharmacological characterization. Synapse 2000, 35:129-136.
68. Rodvelt K.R., Schachtman T.R., Kracke G.R., Miller D.K. NMDA receptor blockade augmented nicotine-evoked dopamine release from rat prefrontal cortex slices. Neuroscience Letters 2008, 440:319-322.
69. Roy T.S., Andrews J.E., Seidler F.J., Slotkin T.A. Nicotine evokes cell death in embryonic rat brain during neurulation. Journal of Pharmacology Experimental Therapy 1998, 287:1136-1144.
70. Roth T.L., Lubin F.D., Sodhi M., Kleinman J.E. Epigenetic mechanisms in schizophrenia. Biochimical and Biophysical Acta 2009, 1790:869-877.
71. Rudin M., Ben-Abraham R., Gazit V., Tendler Y., Tashlykov V., Katz Y. Single-dose ketamine administration induces apoptosis in neonatal mouse brain. Journal Basic and Clinical Physiology and Pharmacology 2005, 16:231-243.
72. Rutten B.P., Mill J. Epigenetic mediation of environmental influences in major psychotic disorders. Schizophrenia Bulletin 2009, 35:1045-1056.
73. Satta R., Maloku E., Zhubi A., Pibiri F., Hajos M., Costa E., et al. Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons. Proceeding of the Natural Acadamy of Sciences 2008, 105:16356-16361.
74. Singh N.P., Mccoy M.T., Tice R.R., Schneider E.L. A simple technique for quantification of low levels of DNA damage in individual cells. Experimental Cell Research 1988, 175:184-191.
75. Slotkin T.A., Lappi S.E., Seidler F.J. Impact of fetal nicotine exposure on development of rat brain regions: critical sensitive periods or effects of withdrawal?. Brain Research Bulletin 1993, 31:319-328.
76. Smith S.E.P., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain in development through interleukin-6. Journal of Neuroscience 2007, 27:10695-10702.
77. Song X., Violin J.D., Seidler F.J., Slotkin T.A. Modeling the developmental neurotoxicity of chlorpyrifos in vitro: macromolecule synthesis in PC12 cells. Toxicology and Applied Pharmacology 1998, 151:182-191.
78. Spencer W.A., Jevabalan J., Kichambre S., Gupta R.C. Oxidatively generated DNA damage after Cu (II) catalysis of dopamine and related catecholamine neurotransmitters and neurotoxis: Role of reactive oxygen species. Free Radical Biology and Medicine 2011, 50:139-147.
79. Stathis S.L., O'Callaghan D.M., Williams G.M., Najman J.M., Andersen M.J., Bor W. Maternal cigarette smoking during pregnancy is an independent predictor for symptoms of middle ear disease at five years postdelivery. Pediatrics 1999, 104:116-120.
80. Stopper H., Schupp N., Fazeli G., Dietel B., Queisser N., Walitza S., et al. Genotoxicity of the neurotransmitter dopamine in vitro. Toxicology in Vitro 2009, 23:640-646.
81. Susser E., St Clair D., He L. Latent effects of prenatal malnutrition on adult health: the example of schizophrenia. Annals New York Academic Science 2008, 1136:85-92.
82. Swerdlow N.R., Bakshi V., Waikar M., Taaid N., Geyer M.A. Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats. Psychopharmacology 1998, 140:75-80.
83. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environmental and Molecular Mutagenesis 2000, 35:206-221.
84. Tomiya M., Fukushima T., Kawai J., Aoyama C., Mitsuhashi S., Santa T., et al. Alterations of plasma and cerebrospinal fluid glutamate levels in rats treated with the N-methyl-D-aspartate receptor antagonist, ketamine. Biomedical Chromatography 2006, 33:628-633.
85. Tolson C.M., Seidler F.J., McCook E.C., Slotkin T.A. Does concurrent or prior nicotine exposure interact with neonatal hypoxia to produce cardiac cell damage?. Teratology 1995, 52:298-305.
86. Van de Berg W.D., Schmitz C., Steinbusch H.W., Blanco C.E. Perinatal asphyxia induced neuronal loss by apoptosis in the neonatal rat striatum: a combined TUNEL and stereological study. Experimental Neurology 2002, 174:29-36.
87. Van Den Buuse M., Garner B., Gogos A., Kusljic S. Importance of animal models in schizophrenia research. Australian and New Zealand Journal of Psychiatry 2005, 39:550-557.
88. Villela I.V., de Oliveira I.M., da Silva J., Henriques J.A. DNA damage and repair in haemolymph cells of golden mussel (Limnoperna fortunei) exposed to environmental contaminants. Mutatation Research 2006, 605:78-86.
89. Wang C., Sadovova N., Fu X., Schmued L., Scallet A., Hanig J., et al. The role of the N-methyl-D-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture. Neuroscience 2005, 132:967-977.
90. Witschi H., Joad J.P., Pinkerton K. The toxicology of environmental tobacco smoke. Annual Review of Pharmacology and Toxicology 1997, 37:29-52.
91. Yildiz D. Nicotine, its metabolism and an overview of its biological effects. Toxiconology 2004, 43:619-632.
92. Zhang X.Y., Chen C., Xiu M.H., Wang F., Qi L.Y., Sun H.Q., et al. The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients. Schizophrenia Research 2009, 113:151-157.
93. Zhao Z., Reece E.A. Nicotine-induced embryonic malformations mediated by apoptosis from increasing intracellular calcium and oxidative stress. Birth Defects Research B Developmental Reproductive Toxicology 2005, 74:383-391.
94. Zouakia A., Guilloteau D., Zimmer L., Besnard J.C., Chalon S. Evolution of dopamine receptors in the rat after neonatal hypoxia-ischemia: autoradiographic studies. Life Science 1997, 60:151-162.